Home › Funds › PARUS FINANCE (UK) Ltd › ELV

PARUS FINANCE (UK) Ltd position in ELV

ELEVANCE HEALTH INC FORMERLY · Health Care

PARUS FINANCE (UK) Ltd reported holding 10,148 shares of ELV (ELEVANCE HEALTH INC FORMERLY) in its Q2 2026 13F filing — a position valued at US$3.9M, representing 1.02% of its reported portfolio and ranking #18 among its reported holdings. PARUS FINANCE (UK) Ltd has disclosed ELV holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)10.15K sh
Reported value held$3.92M
Portfolio Weight1.02%
First reportedQ3 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How PARUS FINANCE (UK) Ltd's ELV position evolved

PARUS FINANCE (UK) Ltd first disclosed a stake in ELV in Q3 2023 at 16,438 shares (US$7.2M). The position peaked in Q2 2024 at 16,236 shares, worth US$8.8M. Across 12 filings, PARUS FINANCE (UK) Ltd increased the stake 3 time(s), trimmed it 7 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 10,148 shares valued at US$3.9M — a reduction of -523 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 16.44K $7.16M New
Q4 2023 16.86K $7.95M Add
Q1 2024 15.63K $8.11M Reduce
Q2 2024 16.24K $8.80M Add
Q3 2024 12.38K $6.44M Reduce
Q4 2024 12.41K $4.58M Hold
Q1 2025 12.05K $5.24M Reduce
Q2 2025 11.26K $4.38M Reduce
Q3 2025 11.09K $3.58M Reduce
Q4 2025 11.24K $3.94M Add
Q1 2026 10.67K $3.12M Reduce
Q2 2026 10.15K $3.92M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ELV and 13F data

ELV (ELEVANCE HEALTH INC FORMERLY) is a Health Care company. 23 other funds we track also report a position in ELV — the largest reported positions include Wellington Management Group (US$3.56B), WELLINGTON MANAGEMENT GROUP LLP (US$3.56B), Sanders Capital, LLC (US$2.25B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ELV

All ELV fund holders →

FAQ

How long has PARUS FINANCE (UK) Ltd held ELV?

PARUS FINANCE (UK) Ltd has disclosed ELV holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is PARUS FINANCE (UK) Ltd's current position in ELV?

As of Q2 2026, PARUS FINANCE (UK) Ltd holds 10.15K shares of ELV (ELEVANCE HEALTH INC FORMERLY), valued at $3.92M, representing 1.02% of its reported portfolio and ranking #18.

Has PARUS FINANCE (UK) Ltd been buying or selling ELV?

In the latest 13F filing (Q2 2026), PARUS FINANCE (UK) Ltd reduced its position in ELV. The position peaked in Q2 2024 at 16.24K shares.

Which other funds hold ELV?

Other major institutional holders of ELV include Wellington Management Group, WELLINGTON MANAGEMENT GROUP LLP, Sanders Capital, LLC, among 23 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.